Sprint Bioscience AB (publ)'s latest marketcap:
As of 04/30/2026, Sprint Bioscience AB (publ)'s market capitalization has reached $36.62 M. According to our data, Sprint Bioscience AB (publ) is the 33584th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 36.62 M |
| Revenue (ttm) | 18.04 M |
| Net Income (ttm) | 9.89 M |
| Shares Out | 105.52 M |
| EPS (ttm) | 0.11 |
| Forward PE | 17.51 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/08/2026 |
Sprint Bioscience AB (publ)'s yearly market capitalization.
| Date | Market Cap(kr) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 06/01/2026 | kr343.98 M | $37.37 M | 121.77% | n/a |
| 12/30/2025 | kr155.11 M | $16.41 M | 40.43% | 41331 |
| 12/30/2024 | kr110.46 M | $9.93 M | -8.82% | 38027 |
| 12/29/2023 | kr121.14 M | $11.94 M | 449.78% | 36313 |
| 12/30/2022 | kr22.03 M | $2.1 M | -88.47% | 40152 |
| 12/30/2021 | kr191.05 M | $21.02 M | 17.26% | 32489 |
| 12/30/2020 | kr162.93 M | $0 | 14.86% | 29572 |
| 12/30/2019 | kr141.86 M | $15.08 M | -32.15% | 27491 |
| 12/28/2018 | kr209.07 M | $23.5 M | 29.83% | 24753 |
| 12/29/2017 | kr161.03 M | $19.58 M | -26.92% | 25597 |
Company Profile
About Sprint Bioscience AB (publ)
Sprint Bioscience AB (publ) is a pharmaceutical company based in Huddinge, Sweden, specializing in the development of innovative cancer treatments. Founded in 2009, the company focuses on advancing therapies through cutting-edge research and drug development.
Key Drug Candidates
- VPS34: A promising drug candidate designed for treating various cancers using immunotherapies.
- TREX1: Developed to enhance immuno-oncology, radiotherapy, and chemotherapy in cancer treatment.
- PETRA01: Another key drug candidate aimed at addressing different forms of cancer.
Research Focus Areas
Beyond its primary drug candidates, Sprint Bioscience is actively engaged in research related to:
- Tumor metabolism
- NASH (Non-Alcoholic SteatoHepatitis)
Frequently Asked Questions
-
What is Sprint Bioscience AB (publ)'s (STO-SPRINT) current market cap?As of 04/30/2026, Sprint Bioscience AB (publ) (including the parent company, if applicable) has an estimated market capitalization of $36.62 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Sprint Bioscience AB (publ) (STO-SPRINT) rank globally by market cap?Sprint Bioscience AB (publ) global market capitalization ranking is approximately 33584 as of 04/30/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.